GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Gross Profit

Q2M Biotech AG (HAM:QBI) Gross Profit : €0.00 Mil (TTM As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Gross Profit?

Q2M Biotech AG's gross profit for the three months ended in . 20 was €0.00 Mil. Q2M Biotech AG's gross profit for the trailing twelve months (TTM) ended in . 20 was €0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Q2M Biotech AG's gross profit for the three months ended in . 20 was €0.00 Mil. Q2M Biotech AG's Revenue for the three months ended in . 20 was €0.00 Mil. Therefore, Q2M Biotech AG's Gross Margin % for the quarter that ended in . 20 was N/A%.

Q2M Biotech AG had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Q2M Biotech AG Gross Profit Historical Data

The historical data trend for Q2M Biotech AG's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Gross Profit Chart

Q2M Biotech AG Annual Data
Trend
Gross Profit

Q2M Biotech AG Quarterly Data
Gross Profit

Competitive Comparison of Q2M Biotech AG's Gross Profit

For the Biotechnology subindustry, Q2M Biotech AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q2M Biotech AG's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q2M Biotech AG's Gross Profit distribution charts can be found below:

* The bar in red indicates where Q2M Biotech AG's Gross Profit falls into.



Q2M Biotech AG Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Q2M Biotech AG's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Q2M Biotech AG's Gross Profit for the quarter that ended in . 20 is calculated as

Gross Profit (Q: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Gross Profit for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Q2M Biotech AG's Gross Margin % for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Q2M Biotech AG  (HAM:QBI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Q2M Biotech AG had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Q2M Biotech AG Gross Profit Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines